Statistics for NeoGenomics (id:5256 NEO)

Valuation metrics

Market cap

1.93B

Enterprise value

2.15B

Trailing P/E (ttm)

-21.94

Forward P/E

75.05

PEG ratio

75.05

Price/Sales (ttm)

2.99

Price/Book (mrq)

2.12

Enterprise Value/Revenue

3.34

Enterprise Value/EBITDA

-4,807.61

Overview

Shares outstanding

128.36M

Float

126.61M

Shares short

4.24M

% Held by insiders

0.01%

% Held by institutions

1.00%

Average volume (10 days)

892.85K

Average volume (90 days)

Price summary

52-Week low

12.77

52-Week high

21.22

52-Week change

-24.35%

Beta

1.18

50-Day moving average

14.67

200-Day moving average

14.86

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-12.07%

Operating margin

-8.39%

Operational effectiveness

Return on assets

-2.76%

Return on equity

-8.38%

Income statement

Revenue (ttm)

5.10

Revenue per share (ttm)

5.10

Quarterly revenue growth (yoy)

Gross profit (ttm)

244.60M

EBITDA

-447,000.00

Net income to common (ttm)

-77,728,000.00

Diluted EPS (ttm)

-0.61

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

387.81M

Total cash per share (mrq)

3.02

Total debt (mrq)

606.27M

Total Debt/Equity (mrq)

66.75

Current ratio (mrq)

199.10%

Book value per share (mrq)

7.09

Cash flow

Cash flow statement

15.01M

Levered free cash flow (LFCF)

9.09M